• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING Back to Search Results
Catalog Number 245122
Device Problem Missing Information (4053)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/17/2023
Event Type  malfunction  
Event Description
It was reported that while using bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml that there was no label or missing label information in 3 tubes.The following information was provided by the initial reporter: three tubes came without the barcode label.Three tubes came without the barcode label and one tube came with a volume of less than 7ml.
 
Manufacturer Narrative
E.7 initial reporter addr 1:(b)(6).H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
The following fields were updated due to additional information: d9: device available for evaluation: yes.D.9:device eval by manufacturer? yes.D9: returned to manufacturer on: 2023-september- 06.H.6 investigation summary material 245122 is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued, and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record review for batch 2265557 was satisfactory per internal procedures.Formulation, filling, labeling, and packaging processes were within specifications.The labeling process for material 245122 includes label reconciliation where the total number of labels issued is reconciled with the total quantity of labels applied to tubes, used in the batch history record, rejected and unused.Any discrepancies must be within allowable limits specified in the labeling control procedure.The label reconciliation for batch 2265557 does not show an excess of labels after manufacturing which would support the incidence of a tube without a label.Qc inspection and testing were satisfactory at time of release.The complaint history was reviewed, and no other complaints for labeling have been taken on this batch.Retention samples from batch 2265557 (100 tubes) were available for inspection.No labeling defects were observed in 100/100 retention samples.All 100/100 retention tubes had a properly affixed, legible, labels and a scannable barcode label.Three photos were received to assist with the investigation: the first photo shows some tubes rubber banded together from batch 2265557.The second and third photos show four tubes from batch 2265557.Three tubes do not have a label, and the fill volume on one tube is lower than expected.No returns were received to assist with the investigation.This complaint can be confirmed.No complaint trends for this defect have been identified for this product; no actions are indicated at this time.Bd will continue to trend complaints for labeling defects.
 
Event Description
It was reported that while using bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml that there was no label or missing label information in 3 tubes.The following information was provided by the initial reporter: three tubes came without the barcode label.Three tubes came without the barcode label and one tube came with a volume of less than 7ml.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17443010
MDR Text Key320225088
Report Number1119779-2023-00826
Device Sequence Number1
Product Code MDB
UDI-Device Identifier30382902451229
UDI-Public30382902451229
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K974883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/17/2024
Device Catalogue Number245122
Device Lot Number2265557
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/17/2023
Initial Date FDA Received08/02/2023
Supplement Dates Manufacturer Received09/07/2023
Supplement Dates FDA Received09/15/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-